RareCyte’s Precision Biology Services include assay development and clinical sample testing in two general categories:
(1) rare cell detection and biomarker characterization (e.g., circulating tumor cells, CTCs) from liquid biopsies
(2) multiplex immunofluorescent tissue imaging and analysis (spatial biology)

Comprehensive end-to-end services on both platforms include custom assay/panel development, pre-clinical and clinical sample testing, analysis and reporting. Services are performed on RareCyte’s custom instrumentation and reagents in our CLIA-accredited laboratory, supporting everything from RUO to CDx assay development.

RareCyte currently supports a wide range of global clinical trials with deep expertise, personalized service, responsiveness, and short turn-around times.